Impact of fill volume on peritoneal clearances and cytokine appearance in peritoneal dialysis

Peritoneal Dialysis International

Volumn 24, Issue 2, 2004, Pages 156-162

  Paniagua, Ramón ^a,e   de Jesús Ventura, Maria ^a   Rodríguez, Ernesto ^a   Sil, Juana ^b   Galindo, Teresa ^b   Hurtado, María Elena ^c   Alcántara, Guadalupe ^c   Chimalpopoco, Amado ^d   González, Isabel ^d   Sanjurjo, Abraham ^e   Barrón, Lourdes ^e   Amato, Dante ^a   Mujais, Salim ^f  

^a Unidad Invest Med Enfermedades   (Mexico)

^b Hospital General Regional Gabriel Mancera   (Mexico)

^c Hospital General Regional 25   (Mexico)

^d Hospital General de Zona IMSS   (Mexico)

^e INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^f BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

Cytokines; Fill volume; Intraperitoneal pressure; Peritoneal clearances; Ultrafiltration

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; CREATININE; CYTOKINE; IMMUNOGLOBULIN G; INTERLEUKIN 6; TRANSFERRIN; TUMOR NECROSIS FACTOR ALPHA; UREA;

ABSORPTION; ADULT; AGED; ARTICLE; BODY SURFACE; CLEARANCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; CYTOKINE PRODUCTION; DIALYSATE; DIASTOLIC BLOOD PRESSURE; FEMALE; FLUID FLOW; HUMAN; MALE; MOLECULAR SIZE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; ULTRAFILTRATION; VOLUMETRY;

EID: 11144353815     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080402400206     Document Type: Article

References (33)

1. National Kidney Foundation. K/DOQI clinical practice guidelines for peritoneal dialysis adequacy, 2000. Am J Kidney Dis 2001; 37(Suppl 1):S56-136.
2. Diaz-Buxo JA. Enhancement of peritoneal dialysis: the PD Plus concept. Am J Kidney Dis 1996; 27:92-8.
3. Keshaviah P, Emerson PF, Vonesh EF, Brandes JC. Relationship between body size, fill volume, and mass transfer area coefficient in peritoneal dialysis. J Am Soc Nephrol 1994; 4:1820-6.
4. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996; 7:198-207.
5. Rocco M, Soucie JM, Pastan S, McClellan WM. Peritoneal dialysis adequacy and risk of death. Kidney Int 2000; 58:446-57.
6. Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 2001; 12:2158-62.
7. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al. Effect of increased peritoneal clearances on mortality in peritoneal dialysis: ADEMEX, a prospective randomized controlled trial. J Am Soc Nephrol 2002; 13:1307-20.
8. Morgera S, Kuchinke S, Budde K, Lun A, Hocher B, Neumayer HH. Volume stress-induced peritoneal endothelin-1 release in continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1999; 10:2585-90.
9. Vlachojannis JG, Tsakas S, Alexandri S, Petropoulou C, Goumenos DS. Continuous ambulatory peritoneal dialysis is responsible for an increase in plasma norepinephrine. Perit Dial Int 2000; 20:322-7.
10. Ventura MJ, Amato D, Correa-Rotter R, Paniagua R. Relationship between fill volume, intraperitoneal pressure, body size, and subjective discomfort perception in CAPD patients. Perit Dial Int 2000; 20:188-93.
11. Bargman J. Complications of peritoneal dialysis related to increased intra-abdominal pressure. Kidney Int Suppl 1993; 40:S75-80.
12. Gomez-Fernandez P, Sanchez-Agudo L, Calatrava JM, Martinez ME, Escuin-Sancho F, Selgas R, et al. Respiratory muscle weakness in uremic patients under continuous ambulatory peritoneal dialysis. Nephron 1984; 36:219-23.
13. Fischbach M, Terzic J, Gaugler C, Bergere V, Munch K, Hamel G, et al. Impact of an increased intraperitoneal fill volume both on tolerance and dialysis effectiveness in children. Adv Perit Dial 1998; 14:258-64.
14. Wanke T, Auinger M, Lahrmann H, Merkle M, Formanek D, Irsigler K, et al. Diaphragmatic function in patients on continuous ambulatory peritoneal dialysis. Lung 1994; 172:231-40.
15. Fischbach M, Terzic J, Menouer S, Haraldsson B. Optimal volume prescription for children on peritoneal dialysis. Perit Dial Int 2000; 20:603-6.
16. Durand PY. Optimization of fill volumes in automated peritoneal dialysis. Perit Dial Int 2000; 20:601-2.
17. Krediet RT, Boeschoten EW, Struijk DG, Arisz L. Differences in the peritoneal transport of water, solutes and proteins between dialysis with two- and with three-liter exchanges. Nephrol Dial Transplant 1988; 3:198-204.
18. Fischbach M, Terzic J, Dangelser C, Schneider P, Roger ML, Geisert J. Improved dialysis dose by optimizing intraperitoneal volume prescription thanks to intraperitoneal measurements in children. Adv Perit Dial 1997; 13:271-3.
19. Fukatsu A, Komatsu Y, Senoh H, Miyai H, Tanaka Y, Oiwa T, et al. Clinical benefits and tolerability of increased fill volumes in Japanese peritoneal dialysis patients. Perit Dial Int 2001; 21:455-61.
20. Twardowski ZJ, Prowant BF, Nolph KD, Martinez AJ, Lampton LM. High volume, low frequency continuous ambulatory peritoneal dialysis. Kidney Int 1983; 23: 64-70.
21. Imholz AL, Koomen GC, Struijk DG, Arisz L, Krediet RT. Effect of an increased intraperitoneal pressure on fluid and solute transport during CAPD. Kidney Int 1993; 44:1078-85.
22. Wang T, Heimbürger O, Cheng HH, Waniewski J, Bergström J, Lindholm B. Effect of increased dialysate fill volume on peritoneal fluid and solute transport. Kidney Int 1997; 52:1068-76.
23. Fischbach M, Desprez P, Terzic J, Lahlou A, Mengus L, Geisert J. Use of intraperitoneal pressure, ultrafiltration and purification dwell times for individual peritoneal dialysis prescription in children. Clin Nephrol 1996; 46:14-16.
24. Zakaria ER, Rippe B. Peritoneal fluid and tracer albumin kinetics in the rat: effects of increases in intraperitoneal hydrostatic pressure. Perit Dial Int 1995; 15:118-28.
25. Pecoits-Filho R, Araujo MR, Lindholm B, Stenvinkel P, Abensur H, Romao Jr JE, et al. Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 2002; 17:1480-6.
26. Carozzi S, Nasini MG, Ravera M, Sanna A, Tirotta A, Lamperi S. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship. Adv Perit Dial 1997; 13:7-12.
27. Zemel D, Imholz AL, de Waart DR, Dinkla C, Struijk DG, Krediet RT. Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPD. Kidney Int 1994; 46:1422-30.
28. Plum J, Fleisch MC, Razeghi P, Fussholler A, Lordnejad MR, Grabensee B. Influence of uremia on cell viability and cytokine release of human peritoneal mesothelial cells. Kidney Blood Press Res 2002; 25:195-201.
29. Libetta C, De Nicola L, Rampino T, De Simone W, Memoli B. Inflammatory effects of peritoneal dialysis: evidence of systemic monocyte activation. Kidney Int 1996; 49:506-11.
30. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994; 15:74-80.
31. Chung SH, Heimburger O, Stenvinkel P, Bergström J, Lindholm B. Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis. Nephrol Dial Transplant 2001; 11:2240-50.
32. Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, et al. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 2002; 8:75-9.
33. Caglar K, Peng Y, Pupim LB, Flakoll PJ, Levenhagen D, Hakim RM, et al. Inflammatory signals associated with hemodialysis. Kidney Int 2002; 62:1408-16.